405 related articles for article (PubMed ID: 29580569)
21. Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression.
Siegel JS; Palanca BJA; Ances BM; Kharasch ED; Schweiger JA; Yingling MD; Snyder AZ; Nicol GE; Lenze EJ; Farber NB
Psychopharmacology (Berl); 2021 Apr; 238(4):1157-1169. PubMed ID: 33483802
[TBL] [Abstract][Full Text] [Related]
22. Ketamine normalizes brain activity during emotionally valenced attentional processing in depression.
Reed JL; Nugent AC; Furey ML; Szczepanik JE; Evans JW; Zarate CA
Neuroimage Clin; 2018; 20():92-101. PubMed ID: 30094160
[TBL] [Abstract][Full Text] [Related]
23. Network Mechanisms of Clinical Response to Transcranial Magnetic Stimulation in Posttraumatic Stress Disorder and Major Depressive Disorder.
Philip NS; Barredo J; van 't Wout-Frank M; Tyrka AR; Price LH; Carpenter LL
Biol Psychiatry; 2018 Feb; 83(3):263-272. PubMed ID: 28886760
[TBL] [Abstract][Full Text] [Related]
24. Effects of 12-week escitalopram treatment on resting-state functional connectivity of large-scale brain networks in major depressive disorder.
Zhang S; Zhou J; Cui J; Zhang Z; Liu R; Feng Y; Feng L; Wang Y; Chen X; Wu H; Jin Y; Zhou Y; Wang G
Hum Brain Mapp; 2023 Apr; 44(6):2572-2584. PubMed ID: 36773284
[TBL] [Abstract][Full Text] [Related]
25. Aberrant connectivity within the default mode network in first-episode, treatment-naïve major depressive disorder.
Chen Y; Wang C; Zhu X; Tan Y; Zhong Y
J Affect Disord; 2015 Sep; 183():49-56. PubMed ID: 26001663
[TBL] [Abstract][Full Text] [Related]
26. Modulation of resting-state functional connectivity in default mode network is associated with the long-term treatment outcome in major depressive disorder.
Ju Y; Wang M; Liu J; Liu B; Yan D; Lu X; Sun J; Dong Q; Zhang L; Guo H; Zhao F; Liao M; Zhang L; Zhang Y; Li L
Psychol Med; 2023 Oct; 53(13):5963-5975. PubMed ID: 36164996
[TBL] [Abstract][Full Text] [Related]
27. [Dysfunctional resting-state connectivity of default mode network in adolescent patients with first-episode drug-naive major depressive disorder].
Li SY; Zhu Y; Wang YL; Lü PP; Zuo WB; Li FY
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3538-3542. PubMed ID: 29275591
[No Abstract] [Full Text] [Related]
28. Functional connectivity of the amygdala subregions and the antidepressant effects of repeated ketamine infusions in major depressive disorder.
Liu H; Wang C; Lan X; Li W; Zhang F; Hu Z; Ye Y; Ning Y; Zhou Y
Eur Psychiatry; 2024 Apr; 67(1):e33. PubMed ID: 38572583
[TBL] [Abstract][Full Text] [Related]
29. Abnormal dynamic functional network connectivity in unmedicated bipolar and major depressive disorders based on the triple-network model.
Wang J; Wang Y; Huang H; Jia Y; Zheng S; Zhong S; Chen G; Huang L; Huang R
Psychol Med; 2020 Feb; 50(3):465-474. PubMed ID: 30868989
[TBL] [Abstract][Full Text] [Related]
30. Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression.
Taraku B; Loureiro JR; Sahib AK; Zavaliangos-Petropulu A; Al-Sharif N; Leaver AM; Wade B; Joshi S; Woods RP; Espinoza R; Narr KL
Brain Behav; 2024 Jun; 14(6):e3511. PubMed ID: 38894648
[TBL] [Abstract][Full Text] [Related]
31. Large-scale dynamic causal modeling of major depressive disorder based on resting-state functional magnetic resonance imaging.
Li G; Liu Y; Zheng Y; Li D; Liang X; Chen Y; Cui Y; Yap PT; Qiu S; Zhang H; Shen D
Hum Brain Mapp; 2020 Mar; 41(4):865-881. PubMed ID: 32026598
[TBL] [Abstract][Full Text] [Related]
32. Brain network functional connectivity and cognitive performance in major depressive disorder.
Albert KM; Potter GG; Boyd BD; Kang H; Taylor WD
J Psychiatr Res; 2019 Mar; 110():51-56. PubMed ID: 30594024
[TBL] [Abstract][Full Text] [Related]
33. Ketamine influences the locus coeruleus norepinephrine network, with a dependency on norepinephrine transporter genotype - a placebo controlled fMRI study.
Liebe T; Li M; Colic L; Munk MHJ; Sweeney-Reed CM; Woelfer M; Kretzschmar MA; Steiner J; von Düring F; Behnisch G; Schott BH; Walter M
Neuroimage Clin; 2018; 20():715-723. PubMed ID: 30238915
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
[TBL] [Abstract][Full Text] [Related]
35. Decreased functional connectivity to posterior cingulate cortex in major depressive disorder.
Yang R; Gao C; Wu X; Yang J; Li S; Cheng H
Psychiatry Res Neuroimaging; 2016 Sep; 255():15-23. PubMed ID: 27500452
[TBL] [Abstract][Full Text] [Related]
36. A treatment-resistant default mode subnetwork in major depression.
Li B; Liu L; Friston KJ; Shen H; Wang L; Zeng LL; Hu D
Biol Psychiatry; 2013 Jul; 74(1):48-54. PubMed ID: 23273724
[TBL] [Abstract][Full Text] [Related]
37. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
Downey D; Dutta A; McKie S; Dawson GR; Dourish CT; Craig K; Smith MA; McCarthy DJ; Harmer CJ; Goodwin GM; Williams S; Deakin JF
Eur Neuropsychopharmacol; 2016 Jun; 26(6):994-1003. PubMed ID: 27133029
[TBL] [Abstract][Full Text] [Related]
38. Functional Connectivity Between Extrastriate Body Area and Default Mode Network Predicts Depersonalization Symptoms in Major Depression: Findings From an A Priori Specified Multinetwork Comparison.
Paul ER; Farmer M; Kämpe R; Cremers HR; Hamilton JP
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jul; 4(7):627-635. PubMed ID: 31103548
[TBL] [Abstract][Full Text] [Related]
39. Resting state brain network function in major depression - Depression symptomatology, antidepressant treatment effects, future research.
Brakowski J; Spinelli S; Dörig N; Bosch OG; Manoliu A; Holtforth MG; Seifritz E
J Psychiatr Res; 2017 Sep; 92():147-159. PubMed ID: 28458140
[TBL] [Abstract][Full Text] [Related]
40. Charting the dorsal-medial functional gradient of the default mode network in major depressive disorder.
Xiao Y; Wang D; Tan Z; Luo H; Wang Y; Pan C; Lan Z; Kuai C; Xue SW
J Psychiatr Res; 2022 Sep; 153():1-10. PubMed ID: 35792340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
